4/15
08:11 am
slno
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
Medium
Report
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
3/28
10:38 am
slno
Rating for SLNO
Low
Report
Rating for SLNO
3/28
10:29 am
slno
Rating for SLNO
Low
Report
Rating for SLNO
3/28
10:29 am
slno
Rating for SLNO
Low
Report
Rating for SLNO
3/28
08:49 am
slno
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at Guggenheim.
Medium
Report
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at Guggenheim.
3/28
08:49 am
slno
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at Guggenheim.
Medium
Report
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at Guggenheim.
3/27
09:18 am
slno
Rating for SLNO
Low
Report
Rating for SLNO
3/27
09:18 am
slno
Rating for SLNO
Low
Report
Rating for SLNO
3/27
09:15 am
slno
Rating for SLNO
Low
Report
Rating for SLNO
3/5
12:52 pm
slno
Rating for SLNO
Low
Report
Rating for SLNO
3/5
10:11 am
slno
Soleno Therapeutics, Inc. (NASDAQ: SLNO) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $74.00 price target on the stock.
Low
Report
Soleno Therapeutics, Inc. (NASDAQ: SLNO) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $74.00 price target on the stock.
3/5
10:11 am
slno
Soleno Therapeutics, Inc. (NASDAQ: SLNO) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $74.00 price target on the stock.
Low
Report
Soleno Therapeutics, Inc. (NASDAQ: SLNO) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $74.00 price target on the stock.
3/3
08:10 am
slno
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $70.00 price target on the stock.
Medium
Report
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $70.00 price target on the stock.